The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

PURPOSE: The goal of these studies was to provide proof of concept for a novel targeted therapy for Glioblastoma Multiforme (GBM). Methods. These studies involve the evaluation of reconstituted high density lipoprotein (rHDL) nanoparticles (NPs) as delivery agents for the drug, mammalian Target of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Berney, Ethan, Sabnis, Nirupama, Panchoo, Marlyn, Raut, Sangram, Dickerman, Rob, Lacko, Andras G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583082/
https://www.ncbi.nlm.nih.gov/pubmed/31275377
http://dx.doi.org/10.1155/2019/1805841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583082/
https://www.ncbi.nlm.nih.gov/pubmed/31275377
http://dx.doi.org/10.1155/2019/1805841

Ejemplares similares